4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-019600
CHIEF OPERATING OFFICER sold 50,000 shares at an average $25.06 ($1,252,826)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · CHIEF OPERATING OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-12 | Sale : show line 1 in the form 10b5-1 | −17,475 | $25.07 | $438,095 | 376,552 | I |
| 2024-07-15 | Sale : show line 2 in the form 10b5-1 | −30,978 | $25.05 | $776,039 | 345,574 | I |
| 2024-07-16 | Sale : show line 3 in the form 10b5-1 | −1,547 | $25.01 | $38,692 | 344,027 | I |
| Open-market sales · 50,000 sh · avg $25.06 · $1,252,826 | ||||||
Loading xslF345X05/form4-07162024_090759.xml…